XBiotech Inc Cash Flow-to-Debt Ratio
XBiotech Inc cash flow-to-debt ratio. XBiotech Inc (XBIT) has a Cash Flow-to-Debt Ratio of -2.36x as of December 2025, meaning its operating cash flow of $-22.95 Million could theoretically repay -2% of its total liabilities ($9.73 Million) in one year. Check XBiotech Inc (XBIT) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of XBiotech Inc (2012–2025)
Cash flow-to-debt ratio of XBiotech Inc from 2012 to 2025. Historical debt coverage capacity for XBiotech Inc across 14 annual periods. Check cash flow reinvestment rate of XBiotech Inc to assess the company's total reinvestment commitment from operating cash flow.
XBiotech Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
XBiotech Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for XBiotech Inc. For the full cash flow conversion analysis, see XBIT operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.10x | $-39.92 Million | $9.73 Million | ▼ -122.9% |
| 2024 | -1.84x | $-30.96 Million | $16.82 Million | ▲ +23.6% |
| 2023 | -2.41x | $-18.73 Million | $7.77 Million | ▲ +7.3% |
| 2022 | -2.60x | $-14.82 Million | $5.70 Million | ▼ -121.7% |
| 2021 | 11.99x | $69.44 Million | $5.79 Million | ▲ +194.0% |
| 2020 | -12.76x | $-65.15 Million | $5.11 Million | ▼ -4178.1% |
| 2019 | -0.30x | $-18.27 Million | $61.25 Million | ▲ +94.7% |
| 2018 | -5.61x | $-16.54 Million | $2.95 Million | ▲ +53.1% |
| 2017 | -11.97x | $-33.65 Million | $2.81 Million | ▼ -107.8% |
| 2016 | -5.76x | $-46.02 Million | $7.99 Million | ▼ -9.1% |
| 2015 | -5.28x | $-33.31 Million | $6.31 Million | ▼ -42.0% |
| 2014 | -3.72x | $-11.70 Million | $3.15 Million | ▲ +64.7% |
| 2013 | -10.54x | $-8.91 Million | $845.00K | ▲ +0.6% |
| 2012 | -10.61x | $-11.63 Million | $1.10 Million | — |